Skip to main content
. 2023 Apr 9;11(4):1133. doi: 10.3390/biomedicines11041133
Akt AKT serine/threonine kinase 1
ATM Ataxia telangiectasia-mutated kinase
ATR Ataxia telangiectasia and Rad3-related kinase
ATRX Alpha-thalassemia/mental retardation x-linked chromatin remodeller
CDK4 Cyclin-dependent kinase 4
c-Myc Cellular myelocytomatosis
GIC50 50% growth inhibitory concentration
KO Knockout
MAP Methotrexate, doxorubicin and cisplatin
MAPK Mitogen-Activated Protein Kinase
MDM2 E3 ubiquitin-protein ligase MDM2
mTOR Mammalian target of rapamycin
OS Osteosarcoma
p53 Tumour suppressor protein 53
Pol I RNA Polymerase I
PI3K Phosphoinositide 3-kinase
rDNA Ribosomal DNA
RB1 Retinoblastoma 1
SL-1 Selective factor 1
tIC50 50% transcription inhibitory concentration
TP53 p53 gene
TSC Tuberous Sclerosis Complex
UBF Upstream binding factor